Evidence map›Paper›PMID 24158479›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis.

Catalina Perdomo, Joshua D Campbell, Joseph Gerrein, Carmen S Tellez, Carly B Garrison, Tonya C Walser, Eduard Drizik, Huiqing Si, Adam C Gower, Jessica Vick and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Connecting the Dots: How MicroRNAs Link Asthma and Atherosclerosis.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Airway Transcriptome as a Biomarker for Early Lung Cancer Detection.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Catalina PerdomoDivision of Computational Biomedicine, Genetics and Genomics Program, and Pulmonary Center, Department of Medicine, Boston University, Boston, MA 02118.
Joshua D Campbell
Joseph Gerrein
Carmen S Tellez
Carly B Garrison
Tonya C Walser
Eduard Drizik
Huiqing Si
Adam C Gower
Jessica Vick
Christina Anderlind
George R Jackson
Courtney Mankus
Frank Schembri
Carl O'Hara
Brigitte N Gomperts
Steven M Dubinett
Patrick Hayden
Steven A Belinsky
Marc E Lenburg
Avrum Spira
Boston University · USInstitute for Biomedicine · ITMatTek Corporation (United States) · USUniversity of California, Los Angeles · USLovelace Respiratory Research Institute · USInstitut thématique Génétique, génomique et bioinformatique · FR

Funding

TARGETING EARLY CHANGES FOR NEW SCREENING STRATEGIESP50CA058184 · NCI · JOHNS HOPKINS UNIVERSITY · PI GABRIELSON, EDWARD W. · 1992 to 2013
$30.5M
The UCLA - Boston University Lung Cancer Biomarker Development LaboratoryU01CA152751 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M., ELASHOFF, DAVID · 2010 to 2015
$5.0M
Airway gene expression in smokers: an early diagnostic biomarker for lung cancerR01CA124640 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SPIRA, AVRUM E · 2007 to 2011
$1.5M
Tissue Engineered In Vitro Human Airway Models of Asthma and COPDR43HL088807 · NHLBI · MATTEK CORPORATION · PI HAYDEN, PATRICK J · 2007 to 2007
$216k
Inflammation in the pathogenesis of lung cancerI01BX000359 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI DUBINETT, STEVEN M. · 2009 to 2018
–
BLRD VA I01 BX000359NCI NIH HHS P50 CA058184NCI NIH HHS P50CA58184NCI NIH HHS R01 CA 124640NCI NIH HHS R01 CA124640NCI NIH HHS U01 CA152751NHLBI NIH HHS R43 HL088807NHLBI NIH HHS R43HL088807-01
6 · The paper itself

Abstract

Smoking is a significant risk factor for lung cancer, the leading cause of cancer-related deaths worldwide. Although microRNAs are regulators of many airway gene-expression changes induced by smoking, their role in modulating changes associated with lung cancer in these cells remains unknown. Here, we use next-generation sequencing of small RNAs in the airway to identify microRNA 4423 (miR-4423) as a primate-specific microRNA associated with lung cancer and expressed primarily in mucociliary epithelium. The endogenous expression of miR-4423 increases as bronchial epithelial cells undergo differentiation into mucociliary epithelium in vitro, and its overexpression during this process causes an increase in the number of ciliated cells. Furthermore, expression of miR-4423 is reduced in most lung tumors and in cytologically normal epithelium of the mainstem bronchus of smokers with lung cancer. In addition, ectopic expression of miR-4423 in a subset of lung cancer cell lines reduces their anchorage-independent growth and significantly decreases the size of the tumors formed in a mouse xenograft model. Consistent with these phenotypes, overexpression of miR-4423 induces a differentiated-like pattern of airway epithelium gene expression and reverses the expression of many genes that are altered in lung cancer. Together, our results indicate that miR-4423 is a regulator of airway epithelium differentiation and that the abrogation of its function contributes to lung carcinogenesis.

Indexed as

AnimalsBiomarkers, TumorCarcinogenesisCell DifferentiationHigh-Throughput Nucleotide SequencingHumansImmunohistochemistryIn Situ HybridizationLung NeoplasmsMiceMicroarray AnalysisMicroRNAsReal-Time Polymerase Chain ReactionRespiratory MucosaBiomarkers, TumorMicroRNAsairway epithelium developmentmicroRNA discoverynext-generation sequencing technologynoncoding RNAtumor suppressor

Identifiers

PMID24158479
PMCPMC3839685
OpenAlexW2085420765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.